Warning Letter — H2 BEV, LLC and H2 RENU, INC
The FDA issued a warning letter to H2 BEV, LLC and H2 RENU, INC. following an evaluation by the Human Foods Program regarding regulatory compliance.
This affects the named entities, their regulatory and marketing departments, and manufacturers of hydrogen-based beverage products making health-related claims.
While the specific violations are not detailed in the excerpt, warning letters from the Human Foods Program typically indicate issues with product labeling, unapproved claims, or manufacturing standards. This enforcement action suggests the FDA is monitoring the marketing and safety of products in this niche beverage category. Regulatory teams should interpret this as a signal that specialized functional beverages remain under scrutiny for potential misbranding or unauthorized drug claims.
Review all product labeling and digital marketing materials to ensure no unapproved health or drug claims are being made. Verify that food products are not positioned as treatments for specific diseases or physiological conditions without appropriate FDA authorization.
FDA Warning Letter issued to: H2 BEV, LLC and H2 RENU, INC. 07/31/2026 — Human Foods Program. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/h2-bev-llc-and-h2-renu-inc-730567-07312026
Open in openFDA / FDA.gov